Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7,130.000 -121.500    -1.68%
11/08 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 3,369
  • Bid/Ask: 7,094.000 / 7,130.000
  • Day's Range: 7,135.000 - 7,222.500
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110665 
Amgen 7,130.000 -121.500 -1.68%
Amgen Reports Q2 Beat, Provides Guidance
Amgen Reports Q2 Beat, Provides Guidance By Investing.com - Aug 04, 2022

By Investing.com Staff Amgen (NASDAQ:AMGN) reported its Q2 results, with EPS of $4.65 coming in better than the consensus estimate of $4.39. Revenue grew 1% year-over-year to $6.59 billion, compared...

Amgen Tops Q2 EPS by 26c, Offers Guidance
Amgen Tops Q2 EPS by 26c, Offers Guidance By Investing.com - Aug 04, 2022

Amgen (NASDAQ:AMGN) reported Q2 EPS of $4.65, $0.26 better than the analyst estimate of $4.39. Revenue for the quarter came in at $6.59 billion versus the consensus estimate of $6.53...

Amgen Earnings, Revenue beat in Q2
Amgen Earnings, Revenue beat in Q2 By Investing.com - Aug 04, 2022

Investing.com - Amgen (NASDAQ:AMGN) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Amgen announced earnings per share of $4.65 on...

Amgen to Acquire ChemoCentryx in $3.7bn Deal
Amgen to Acquire ChemoCentryx in $3.7bn Deal By Investing.com - Aug 04, 2022

By Sam Boughedda Amgen (NASDAQ:AMGN) is set to acquire ChemoCentryx (NASDAQ:CCXI) for $52 per share in cash, it was announced Thursday, representing an enterprise value of approximately $3.7...

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMGN Comments

Write your thoughts about Amgen
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email